Martins, Ralph N ;
Villemagne, Victor ;
Sohrabi, Hamid R...
Martins , R N , Villemagne , V , Sohrabi , H R , Chatterjee , P , Shah , T M , Verdile , G , Fraser , P , Taddei , K , Gupta , V B , Rainey-Smith , S R , Hone , E , Pedrini , S , Lim , W L , Martins , I , Frost , S , Gupta , S , O'Bryant , S , Rembach , A , Ames , D , Ellis , K , Fuller , S J , Brown , B , Gardener , S L , Fernando , B , Bharadwaj , P , Burnham , S , Laws , S M , Barron , A M , Goozee , K , Wahjoepramono , E J , Asih , P R , Doecke , J D , Salvado , O , Bush , A I , Rowe , C C , Gandy , S E & Masters , C L 2018 , ' Alzheimer's disease : a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies-gains from AIBL and DIAN cohort studies ' , Journal of Alzheimer's Disease , vol. 62 , no. 3 , pp. 965-992 . https://doi.org/10.3233/JAD-171145.
,
2018
